PHARMACOKINETICS AND SAFETY OF THE ANTI-HUMAN CYTOMEGALOVIRUS DRUG LETERMOVIR IN SUBJECTS WITH HEPATIC IMPAIRMENT ArticleKropeit D., Mccormick D., Erb-Zohar K., Moiseev V.S., Kobalava Z.D., Stobernack H.-P., Zimmermann H., Rübsamen-Schaeff H.British Journal of Clinical Pharmacology. Том 83. 2017. С. 2678-2686
PHARMACOKINETICS OF SERELAXIN IN PATIENTS WITH HEPATIC IMPAIRMENT: A SINGLE-DOSE, OPEN-LABEL, PARALLEL GROUP STUDY ArticleKobalava Z., Villevalde S., Kotovskaya Y., Hinrichsen H., Petersen-Sylla M., Zaehringer A., Pang Y., Rajman I., Canadi J., Dahlke M., Lloyd P., Halabi A.British Journal of Clinical Pharmacology. Том 79. 2015. С. 937-945
EFFECT OF LOCAL HYPERTHERMIA OF THE BLADDER ON MITOMYCIN C PHARMACOKINETICS DURING INTRAVESICAL CHEMOTHERAPY FOR THE TREATMENT OF SUPERFICIAL TRANSITIONAL CELL CARCINOMA ArticleParoni Rita, Salonia Andrea, Lev Avigdor, Da Pozzo L.F., Cighetti Giuliana, Montorsi Francesco, Rigatti Patrizio, Colombo RenzoBritish Journal of Clinical Pharmacology. Том 52. 2001. С. 273-278